Home/Modiblast Pharma/Dr.-Ing. Nikolaus Schaller
DN

Dr.-Ing. Nikolaus Schaller

Co-Founder, CFO, COO, CIO

Modiblast Pharma

Therapeutic Areas

Modiblast Pharma Pipeline

DrugIndicationPhase
MB101Acute Myeloid Leukemia (AML) - Maintenance TherapyPre-clinical